Company intelligence
BioFermion
Innovating BioAI and Healthcare Solutions
1 employees
3 public signals
Verified activity
Signals from BioFermion
3 published signals
Capital & Finance
BioFermion's Isomorphic Labs raised $2.1 billion to scale AI-driven drug discovery and expand its AI, engineering and clinical teams.
Reported by Valeria Ossovskaya PhD
Capital & Finance
BioFermion notes that NVIDIA and Eli Lilly are building an AI co-innovation lab in the San Francisco Bay Area with plans to invest up to $1 billion over five years.
Reported by Valeria Ossovskaya PhD
Capital & Finance
BioFermion notes that Anthropic is pushing deeper into healthcare and biology as it prepares for a potential blockbuster IPO.
Reported by Valeria Ossovskaya PhD